Takara Bio USA Exhibitor Tutorial: Streamlining the drug discovery workflow with human iPS-derived cells and ICELL8 cx single-cell technology

Novel human iPS-derived hepatocytes and intestinal epithelial cells for more accurate disease modeling and drug discovery

Human iPS-derived cells provide a renewable source of cells that can be used for a variety of downstream applications to study and treat disease. We have developed robust protocols for highly efficient differentiation of hiPSCs to definitive endoderm and further differentiation into hepatocytes and intestinal epithelial cells. These cells are mature and functional, providing researchers with improved models to advance their disease and drug discovery research.

Efficient, versatile assay development using the ICELL8 cx Single-Cell System with CELLSTUDIO Software

Developing new assays for high-throughput sample analysis—whether it’s single cells, organoids, or nucleic acids—requires open and flexible solutions. The ICELL8® cx Single-Cell System was designed with these needs in mind and integrates cell dispensing, imaging, and processing steps on one platform. The included ICELL8 cx CELLSTUDIO™ v2.0 Software provides a simple graphical user interface for developers to design, test, and improve their own miniaturized protocols or next-generation sequencing assays. The versatility of the ICELL8 cx system enables assay developers to continue innovation in clinical research, pharmaceutical discovery, and applied spaces.